478 related articles for article (PubMed ID: 2111051)
21. Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime.
Takada A; Takada Y; Urano T; Sakakibara K; Rydzewski A
Thromb Res; 1990 Jan; 57(1):13-20. PubMed ID: 2105539
[TBL] [Abstract][Full Text] [Related]
22. Fibrinolysis system in patients with bronchial asthma.
Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
[TBL] [Abstract][Full Text] [Related]
23. The influence of hyperestrogenism during in vitro fertilization on the fibrinolytic mechanism.
Lox C; Cañez M; Prien S
Int J Fertil Womens Med; 1998; 43(1):34-9. PubMed ID: 9580312
[TBL] [Abstract][Full Text] [Related]
24. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
[TBL] [Abstract][Full Text] [Related]
25. Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms.
Lindholt JS; Jørgensen B; Shi GP; Henneberg EW
Eur J Vasc Endovasc Surg; 2003 Jun; 25(6):546-51. PubMed ID: 12787697
[TBL] [Abstract][Full Text] [Related]
26. Plasminogen activator inhibitor activity in bacterial infection.
Páramo JA; Fernández Diaz FJ; Rocha E
Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
[TBL] [Abstract][Full Text] [Related]
27. Fluctuation of tPA and PAI-1 antigen levels in plasma: difference of their fluctuation patterns between male and female.
Urano T; Sumiyoshi K; Nakamura M; Mori T; Takada Y; Takada A
Thromb Res; 1990 Oct; 60(2):133-9. PubMed ID: 2126399
[TBL] [Abstract][Full Text] [Related]
28. Alpha 2-antiplasmin, plasminogen activator inhibitor (PAI) and dilute blood clot lysis time in selected disease states.
Cucuianu M; Knauer O; Roman S
Thromb Haemost; 1991 Nov; 66(5):586-91. PubMed ID: 1725069
[TBL] [Abstract][Full Text] [Related]
29. Levels of three hemostatic factors in relation to serum lipids. Monocyte procoagulant activity, tissue plasminogen activator, and type-1 plasminogen activator inhibitor.
Crutchley DJ; McPhee GV; Terris MF; Canossa-Terris MA
Arteriosclerosis; 1989; 9(6):934-9. PubMed ID: 2511826
[TBL] [Abstract][Full Text] [Related]
30. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
31. Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus.
Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Díaz-Gomez F; Pacheco-Pantoja E; Drenkard C; Alarcón-Segovia D
Am J Hematol; 1991 May; 37(1):9-13. PubMed ID: 1902623
[TBL] [Abstract][Full Text] [Related]
32. Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential.
Onundarson PT; Francis CW; Marder VJ
J Lab Clin Med; 1992 Jul; 120(1):120-8. PubMed ID: 1613318
[TBL] [Abstract][Full Text] [Related]
33. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
Coolman M; de Groot CJ; Steegers EA; Geurts-Moespot A; Thomas CM; Steegers-Theunissen RP; Sweep FC
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
[TBL] [Abstract][Full Text] [Related]
34. Plasminogen activator inhibitor (PAI) in obese men and obese women.
Cucuianu M; Lanczek M; Roman S
Rom J Intern Med; 1993; 31(3):183-92. PubMed ID: 8130756
[TBL] [Abstract][Full Text] [Related]
35. Changes in plasma levels of tissue plasminogen activator and its inhibitor in aged myocardial infarction patients.
Chen HZ; Jia HY; Song HY; Wang JY
Chin Med J (Engl); 1990 Jul; 103(7):541-5. PubMed ID: 2119970
[TBL] [Abstract][Full Text] [Related]
36. A modified quantitative whole blood clot lysis method for general laboratory analysis of fibrinolysis.
Kahn MB; Palmer S; Marlar RA; Fink L
Thromb Res; 1990 Jul; 59(1):171-81. PubMed ID: 2119074
[TBL] [Abstract][Full Text] [Related]
37. [Fibrinolytic and peripheral serotonergic system in patients with glomerulonephritis].
Małyszko J; Małyszko J; Myśliwiec M; Pawlak D; Buczko W
Przegl Lek; 1995; 52(9):428-30. PubMed ID: 8834642
[TBL] [Abstract][Full Text] [Related]
38. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
Tran-Thang C; Fasel-Felley J; Pralong G; Hofstetter JR; Bachmann F; Kruithof EK
Thromb Haemost; 1989 Sep; 62(2):651-3. PubMed ID: 2510345
[TBL] [Abstract][Full Text] [Related]
39. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
[TBL] [Abstract][Full Text] [Related]
40. [Study on fibrinolysis and platelet function].
Deguchi K; Murashima S; Nishikawa M; Shirakawa S
Nihon Rinsho; 1992 Feb; 50(2):297-302. PubMed ID: 1613983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
